InsidersTradesSigma
Follow the Cohance Lifesciences stock price and the full directors' dealings record of the company, a listed equity based in India. Shares trade on the IN market, under the authority of SEBI (PIT + SAST). Market capitalisation: €172.5bn. The latest transaction was reported on 25 August 2026 (Disposal). Among the most active insiders: Jusmiral Holdings Limited. Every trade is openly available.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
Cohance Lifesciences是一家专注于在生命科学领域为医疗保健行业开发创新解决方案的公司。它在XBOM上市。